C2C: COMBINE-2 for Cabotegravir+Rilpivirine LA Regimen - A Prospective Cohort Study to Monitor Effectiveness, Adherence and Resistance (215160)

26/08/2021
14/10/2026
EU PAS number:
EUPAS42609
Study
Ongoing
Documents
Study protocol
Initial protocol
English (1.47 MB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.